Tech Company Financing Transactions

Medigate Funding Round

Medigate secured a $15 million Series A investment round on 1/30/2019. Investors included U.S. Venture Partners, Blumberg Capital and YL Ventures.

Transaction Overview

Company Name
Medigate
Announced On
1/30/2019
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors

U.S. Venture Partners (Lead Investor) (Jacques Benkoski)

Blumberg Capital (Bruce Taragin)

YL Ventures (Yoav Leitersdorf)

Proceeds Purpose
The company plans to use the funds to accelerate growth and triple headcount across R&D, sales, marketing and customer success over the next 18 months.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
134 N 4th St.
Brooklyn, NY 11249
USA
Phone
(855) 908-0775
Website
www.medigate.io
Email Address
[email protected]
Overview
Medigate is the industry's first and leading dedicated medical device security and asset management platform, enabling providers to deliver secure, connected care. Medigate fuses the knowledge and understanding of medical workflow and device identity and protocols with the reality of today's cybersecurity threats.
Profile
Medigate LinkedIn Company Profile
Social Media
Medigate Company Twitter Account
Company News
Medigate News
Facebook
Medigate on Facebook
YouTube
Medigate on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jonathan Langer
  Jonathan Langer LinkedIn Profile  Jonathan Langer Twitter Account  Jonathan Langer News  Jonathan Langer on Facebook
Vice President
Kobi Rubin
  Kobi Rubin LinkedIn Profile  Kobi Rubin Twitter Account  Kobi Rubin News  Kobi Rubin on Facebook
VP - Customer Service
Roy Gordon
  Roy Gordon LinkedIn Profile  Roy Gordon Twitter Account  Roy Gordon News  Roy Gordon on Facebook
VP - Engineering
Stephan Goldberg
  Stephan Goldberg LinkedIn Profile  Stephan Goldberg Twitter Account  Stephan Goldberg News  Stephan Goldberg on Facebook
VP - Marketing
Beth Ellis
  Beth Ellis LinkedIn Profile  Beth Ellis Twitter Account  Beth Ellis News  Beth Ellis on Facebook
VP - Product Management
Pini Pinhasov
  Pini Pinhasov LinkedIn Profile  Pini Pinhasov Twitter Account  Pini Pinhasov News  Pini Pinhasov on Facebook
VP - R & D
Itay Kirshenbaum
  Itay Kirshenbaum LinkedIn Profile  Itay Kirshenbaum Twitter Account  Itay Kirshenbaum News  Itay Kirshenbaum on Facebook
VP - Sales
Herve Bourgeois
  Herve Bourgeois LinkedIn Profile  Herve Bourgeois Twitter Account  Herve Bourgeois News  Herve Bourgeois on Facebook
VP - Sales
Tyson Hempel
  Tyson Hempel LinkedIn Profile  Tyson Hempel Twitter Account  Tyson Hempel News  Tyson Hempel on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/30/2019: Acorns venture capital transaction
Next: 1/30/2019: Lyndra Therapeutics venture capital transaction

 

Share this article

 

Where The Data Comes From

We document funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.